1. The beat-that-fell-flat — separate the self-set guide from the "whisper"
The repeatable method
- When a stock drops hard on an earnings "miss," check what it actually missed: the company's own guidance, the published consensus, or an unofficial "whisper number" the most aggressive bulls priced in.
- A name that beat every self-set metric but fell short of a whisper has been sold on expectations, not fundamentals — a sentiment dislocation, not a thesis break.
- Confirm the franchise is intact: no lost marquee customers, renewal rate steady, backlog (RPO/cRPO) still growing.
Here: NOW beat on sub-rev/EPS/margin/FCF but fell ~11% only because its 19.5–20% guide missed a 22% whisper — with 98% renewal and accelerating cRPO intact.
Watch for
- Big post-print drops where the company met its own guide; whether the franchise metrics (renewal, RPO) actually deteriorated.
2. Invert the disruption narrative — find where the feared trend is a tailwind
The repeatable method
- Take the consensus disruption story (here: "AI agents make enterprise software unnecessary") and test it against what the company architecturally does.
- Ask whether the company is the layer the new technology must route through — a system of record AI must read before acting and write after — rather than a layer it replaces.
- If so, the feared trend increases usage; quantify the new usage driver (decisions/queries scaling from hundreds to tens of thousands per day).
Here: NOW is the enterprise system of record every AI agent must read/write, so the AI transition makes "owning the authoritative record the most valuable position in the stack."
Watch for
- Companies sold on a disruption theme that are actually the mandatory control point for that disruption; usage/query-volume growth as confirmation.
3. Spot the consumption-revenue meter — usage-based pricing on a fixed cost base
The repeatable method
- Look for a shift from seat-based to consumption-based pricing (tokens/packs charged per AI action) — it decouples revenue from headcount.
- Pair the autonomous-resolution rate (here 90% of IT tickets) with the consumption model: every automated action rings the register against a fixed infrastructure cost = operating leverage.
- Track the new AI line's net-new ACV growth as the leading signal of the consumption ramp.
Here: NOW's Now Assist "Assist Packs" charge for AI-agent activity, net-new ACV more than doubled, 90% of tickets auto-resolved — "the revenue meter spinning."
Watch for
- Net-new ACV of the AI module; autonomous-resolution percentages climbing as the consumption layer compounds.
4. Cash-adjust the multiple, then cross-rank against slower growers
The repeatable method
- Strip net cash out of the market cap before judging "expensive" — a big cash pile lowers the true EV/sales and EV/FCF.
- Anchor the multiple to the company's own 5–10-year range (NOW's 8× P/S is its lowest since 2016) and to the precedent that followed (a 400%+ move).
- Sanity-check by ranking it against slower-growing names on the same metric — if a 20%-grower trades below a low-growth industrial, the mispricing is explicit.
Here: NOW ~6× sales net of $10B cash, sub-18× FCF, PEG ~0.95 — trading below CAT/DE at ~30× earnings despite far higher growth.
Watch for
- A high-grower at a decade-low multiple after cash adjustment; a faster grower priced under a slower one on the same yardstick.
5. The double insider tell — open-market buy plus cancelled 10b5-1 plans
The repeatable method
- Note open-market purchases by the CEO (cash, not grants) at the depressed price as a confidence signal.
- Layer in the stronger, rarer tell: executives simultaneously cancelling pre-planned 10b5-1 sale programs — they don't want to be seen selling.
- Use the combination as corroboration of the mispricing, not a standalone thesis.
Here: NOW CEO McDermott bought ~$3M (28,682 sh @ ~$105) in the open market while senior leaders cancelled their 10b5-1 sale plans.
Watch for
- Form 4 open-market CEO buys at lows; cancellations of scheduled 10b5-1 sale programs.
6. Wait for the base, not the knife — volume signature + a dated catalyst
The repeatable method
- Identify the structural long-term support level and accept the downtrend may not yet be broken — don't "catch a falling knife."
- Look for a constructive volume signature (heavier buying than selling on down days) that precedes a base rather than a continuation lower.
- Time conviction to a dated catalyst (next earnings) that can flip the narrative, given a setup (prior beat + accelerating backlog) that favors another beat.
Here: NOW support ~$80, downtrend not yet arrested, but 6 weeks of heavier down-day buying + the Apr-22 Q1 print (guide $3.65–3.66B) as the narrative-flip catalyst.
Watch for
- Down-day buying volume building a base; the next earnings date as the entry-confirmation trigger.